Layperson-Administered Naloxone Trends Reported in Emergency Medical Service Activations, 2020-2022

• Published in: JAMA network open 2024-10, Vol.7 (10), p.e2439427
• Main Authors: Gage, Christopher B, Powell, Jonathan R, Ulintz, Alexander, Cash, Rebecca E, Lyons, Michael S, Wang, Henry, Panchal, Ashish R
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Cross-Sectional Studies; Drug overdose; Drug Overdose - drug therapy; Drug Overdose - prevention & control; Emergency medical care; Emergency Medical Services - statistics & numerical data; Emergency Medicine; Emergency services; Female; Humans; Male; Middle Aged; Naloxone - administration & dosage; Naloxone - therapeutic use; Narcotic Antagonists - administration & dosage; Narcotic Antagonists - therapeutic use; Narcotics; Online Only; Opiate Overdose - drug therapy; Original Investigation; Pharmacists; Retrospective Studies; Trends; United States; Young Adult
• ISSN: 2574-3805; 2574-3805
• DOI: 10.1001/jamanetworkopen.2024.39427

Layperson-administered naloxone (LAN) is a powerful but incompletely characterized intervention to prevent opioid-related overdose mortality. LAN trends are relevant to policy and strategic planning in naloxone distribution initiatives. To assess the 2-year LAN trend for persons in the United States receiving naloxone during emergency medical services (EMS) activations. This retrospective cross-sectional study was conducted in the United States from June 2020 to June 2022 among 65 621 195 EMS activations from 911 responses, EMS standbys, or when EMS crews functioned in an ambulance intercept role or during mutual aid to another ambulance response. Activations within health care settings and interfacility or medical transports were excluded. Data are from the National Emergency Medical Services Information System (NEMSIS), the national EMS patient care record database. From June 2020 to June 2022, NEMSIS included more than 96 million EMS activations from nearly 14 000 agencies across 54 states and territories. EMS clinician-reported LAN. The primary outcome was the trend of receiving LAN, measured by EMS clinician documentation. From June 2020 to June 2022, EMS reported 744 078 patients receiving naloxone, with 24 990 (3.4%) involving LAN. Patients were predominantly male (17 331 [69.4%]) and had a median (IQR) age of 42 (31-56) years, with the majority treated in urban homes or residences (21 692 [86.8%] urban; 13 223 [52.9%] in-home or residence). Of the total naloxone recipients, 243 985 patients (32.8%) had suspected drug overdose documentation as either the primary or secondary impression. Overall, the percentage change in naloxone administration rates decreased 6.1% over the study period (from 1140.1 [95% CI, 1135.1-1145.1] per 100 000 EMS activations to 1070.1 [95% CI, 1064.9-1075.3] per 100 000 EMS activations), while the percentage change of persons receiving LAN increased 43.5% (from 30.0 [95% CI, 29.2-30.8] per 100 000 EMS activations to 43.1 [95% CI, 42.0-44.1] per 100 000 EMS activations). In this cross-sectional study, the LAN rate increased from June 2020 to June 2022 as reported in the national EMS database. These findings help inform policies and practices aimed at mitigating the devastating impacts of the opioid epidemic and saving lives. Novel public health strategies are needed to measure the effects of this intervention nationally, evaluate approaches to expand naloxone distribution, and address naloxone usage barriers.